drugset / Trial / NCT06546254
1% Lidocaine Paracervical Block for Endometrial Biopsy
RandomizedParallel-groupTriple-blindOther
Summary
The objective of this study is to to determine whether 1% lidocaine paracervical block reduces pain during endometrial biopsy in comparison to no intervention. The proposed study is a double-blind randomized controlled trial (RCT). Each participant will be randomly assigned to one of two arms: 1. intervention (paracervical block - 10 mL 1% lidocaine with epinephrine) 2. control (gently tapping the cervicovaginal junction with a capped needle) The primary outcome will be a global pain score, which will be patient-reported by the 100 mm Visual Analogue Scale (VAS) following the procedure.
Timeline
- Start
- 2025-06-19
- Primary completion
- 2026-01-22
- Completion
- 2026-01-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 1 % | Other |
| Subject | Lidocaine | Other / unclassified | 10 ml | Other |
Indications
No indication recorded.